Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation

Acta Oncologica

Volumn 45, Issue 7, 2006, Pages 890-896

  Hodge, Wes ^a   Tomé, Wolfgang A ^a   Jaradat, Hazim A ^a   Orton, Nigel P ^a   Khuntia, Deepak ^a   Traynor, Anne ^a   Weigel, Tracey ^a   Mehta, Minesh P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; IMMOBILIZATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; MALE; MEGAVOLTAGE RADIOTHERAPY; PRIORITY JOURNAL; RESIDUAL VOLUME; TUMOR REGRESSION;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEASIBILITY STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; RADIOSURGERY; RADIOTHERAPY; SURGERY, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 33748848155     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860600907329     Document Type: Conference Paper

References (19)

1. Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-55.
2. Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 2001;51:666-70.
3. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010-5.
4. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427-31.
5. Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003;56:126-35.
6. Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004;60:186-96.
7. Keall P. 4-dimensional computed tomography imaging and treatment planning. Semin Radiat Oncol 2004;14:81-90.
8. Zhang T, Orton NP, Tomé WA. On the automated definition of mobile target volumes from 4D-CT images for stereotactic body radiotherapy. Med Phys 2005;32:3493-502.
9. Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000; 48:1015-24.
10. Tomé WA, Fenwick JD. Letter to the Editor: Analysis of radiation-induced liver disease using the Lyman NTCP model: In regard to Dawson et al. IJROBP 2002;53:810-21.
11. Int J Radiat Oncol Biol Phys 2004;58:1318-9.
12. Fowler JF, Tomé WA, Fenwick JD, Mehta MP. A challenge to conventional radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:1241-56.
13. Tomé WA, Fenwick JD, Mehta MP. How can tumor effect and normal tissue effect be balanced in Stereotactic Body Radiotherapy. Radiosurgery 2006;6:87-98.
14. Tomé WA, Fowler JF. On cold spots in tumor subvolumes. Med Phys 2002;29:1590-8.
15. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205-16.
16. Siker ML, Tomé WA, Mehta MP. Tumor volume changes on serial imaging with megavoltage CT for Non-Small Lung cancer during Intensity Modulated Radiotherapy: How reliable, consistent and meaningful is the effect? Int J Radiat Oncol Biol Phys 2006 (in press).
17. Martel MK, Ten Haken RK, Hazuka MB, Kessler ML, Strawderman M, Turrisi AT, et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer 1999;24:31-7.
18. Rosenzweig KE, Fox JL, Yorke E, Amols H, Jackson A, Rusch V, et al. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer 2005;103:2118-27.
19. Miller KL, Shafman TD, Anscher MS, Zhou SM, Clough RW, Garst JL, et al. Bronchial stenosis: An underreported complication of high-dose external beam radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys 2005;61:64-9.